CoChat

Constructing biomimetic liver models through biomaterials and vasculature engineering

Open access

The DOI matches its Crossref record; 214 of the 215 references it cites were found in a registry or an index.

Abstract

The occurrence of various liver diseases can lead to organ failure of the liver, which is one of the leading causes of mortality worldwide. Liver tissue engineering see the potential for replacing liver transplantation and drug toxicity studies facing donor shortages. The basic elements in liver tissue engineering are cells and biomaterials. Both mature hepatocytes and differentiated stem cells can be used as the main source of cells to construct spheroids and organoids, achieving improved cell function. To mimic the extracellular matrix (ECM) environment, biomaterials need to be biocompatible and bioactive, which also help support cell proliferation and differentiation and allow ECM deposition and vascularized structures formation. In addition, advanced manufacturing approaches are required to construct the extracellular microenvironment, and it has been proved that the structured three-dimensional culture system can help to improve the activity of hepatocytes and the characterization of specific proteins. In summary, we review biomaterials for liver tissue engineering, including natural hydrogels and synthetic polymers, and advanced processing techniques for building vascularized microenvironments, including bioassembly, bioprinting and microfluidic methods. We then summarize the application fields including transplant and regeneration, disease models and drug cytotoxicity analysis. In the end, we put the challenges and prospects of vascularized liver tissue engineering.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/rb/rbac079

Cites

214 of 214 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical abstract
Graphical abstract CC BY · PubMed Central
Figure 1. Schematic of vascularized liver tissue engineering (created with BioRender.com).
Figure 1. Schematic of vascularized liver tissue engineering (created with BioRender.com).CC BY · PubMed Central
Figure 2. Structure and elements of the liver (created with BioRender.com).
Figure 2. Structure and elements of the liver (created with BioRender.com).CC BY · PubMed Central
Figure 3. Biomaterials used in the vascularized liver tissue engineering. (a) Pluronic and alginate with high applicability. Adapted with permission from Ref. [140]. (b) Collagen type I with hyaluronic acid. Adapted with permission from Ref. [149]. (c) Gelatin. (ci) Gelatin scaffolds. Adapted with permission from Ref. [71]. (cii) Photocrosslinking of GelMA, producing vascularized tissues with complex shapes. Adapted with permission from Ref. [147]. (d) dECM bioink with enhanced printability and mechanical properties. Adapted with permission from Ref. [151]. (e) Synthetic polymers. (ei) PCL mixed with biodegradable hollow fibers (HF). Adapted with permission from Ref. [156]. (eii) PLGA scaffolds. Adapted with permission from Ref. [157]. (f) Cellulose nanocrystals (CNC). Adapted with permission from Ref. [164].
Figure 3. Biomaterials used in the vascularized liver tissue engineering. (a) Pluronic and alginate with high applicability. Adapted with permission from Ref. [140]. (b) Collagen type I with hyaluronic acid. Adapted with permission from Ref. [149]. (c) Gelatin. (ci) Gelatin scaffolds. Adapted with permission from Ref. [71]. (cii) Photocrosslinking of GelMA, producing vascularized tissues with complex shapes. Adapted with permission from Ref. [147]. (d) dECM bioink with enhanced printability and mechanical properties. Adapted with permission from Ref. [151]. (e) Synthetic polymers. (ei) PCL mixed with biodegradable hollow fibers (HF). Adapted with permission from Ref. [156]. (eii) PLGA scaffolds. Adapted with permission from Ref. [157]. (f) Cellulose nanocrystals (CNC). Adapted with permission from Ref. [164].CC BY · PubMed Central
Figure 4. Bioprinted vascularized liver models. (a) Inkjet-based bioprinting. Adapted with permission from Ref. [177]. (b) Photocuring-based bioprinting. Adapted with permission from Ref. [189]. (c) Extrusion-based bioprinting. (ci) Pre-set micro-extrusion printing. Adapted with permission from Ref. [102]. (cii) Coaxial extrusion printing. Adapted with permission from Ref. [67]. (ciii, civ) Sacrificial printing. Adapted with permission from Ref. [69, 187]. (d) Microvascular induction. (di) Microvascular induction to generate liver organoids. Adapted with permission from Ref. [103]. (dii) Microvascular induction to generate hepatic spheroids. Adapted with permission from Ref. [196].
Figure 4. Bioprinted vascularized liver models. (a) Inkjet-based bioprinting. Adapted with permission from Ref. [177]. (b) Photocuring-based bioprinting. Adapted with permission from Ref. [189]. (c) Extrusion-based bioprinting. (ci) Pre-set micro-extrusion printing. Adapted with permission from Ref. [102]. (cii) Coaxial extrusion printing. Adapted with permission from Ref. [67]. (ciii, civ) Sacrificial printing. Adapted with permission from Ref. [69, 187]. (d) Microvascular induction. (di) Microvascular induction to generate liver organoids. Adapted with permission from Ref. [103]. (dii) Microvascular induction to generate hepatic spheroids. Adapted with permission from Ref. [196].CC BY · PubMed Central
Figure 5. Microfluidics-based vascularized liver models. (a) Liver sinusoidal fold chip. Adapted with permission from Ref. [30]. (b) Bionic liver lobule chip. Adapted with permission from Ref. [199]. (c) Fluid-coupled multiorgan chip. Adapted with permission from Ref. [201]. (d) Nonalcoholic fatty liver organ chip. Adapted with permission from Ref. [202].
Figure 5. Microfluidics-based vascularized liver models. (a) Liver sinusoidal fold chip. Adapted with permission from Ref. [30]. (b) Bionic liver lobule chip. Adapted with permission from Ref. [199]. (c) Fluid-coupled multiorgan chip. Adapted with permission from Ref. [201]. (d) Nonalcoholic fatty liver organ chip. Adapted with permission from Ref. [202].CC BY · PubMed Central
Figure 6. Applications of vascularized liver tissue. (a) Transplanted liver tissue into the liver-injured rats. Adapted with permission from Ref. [75]. (b) Drug cytotoxicity analysis. (bi) Vascularized hepatic lobular organoids for drug cytotoxicity analysis. Adapted with permission from Ref. [170]. (bii) Mechanism of action of several known hepatotoxic drugs and one experimental compound. Adapted with permission from Ref. [66]. (c) Disease models. (ci) Liver fibrosis model. Adapted with permission from Ref. [82] (cii) Cancer model [209]. (ciii) Virus transfection model. Adapted with permission from Ref. [210].
Figure 6. Applications of vascularized liver tissue. (a) Transplanted liver tissue into the liver-injured rats. Adapted with permission from Ref. [75]. (b) Drug cytotoxicity analysis. (bi) Vascularized hepatic lobular organoids for drug cytotoxicity analysis. Adapted with permission from Ref. [170]. (bii) Mechanism of action of several known hepatotoxic drugs and one experimental compound. Adapted with permission from Ref. [66]. (c) Disease models. (ci) Liver fibrosis model. Adapted with permission from Ref. [82] (cii) Cancer model [209]. (ciii) Virus transfection model. Adapted with permission from Ref. [210].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 201–214 of 214

Research works printed but not linked: 1

  1. He, 2016, Research on the printability of hydrogels in 3D bioprinting, Sci Rep, 6, 29977, 10.1038/srep29977 · DOI · Paper page

Cited by

See all 45

Metadata

Authors
Lv, W., Zhou, H., Aazmi, A., Yu, M., Xu, X., Yang, H., Huang, Y. Y. S., & Ma, L.
Affiliations
  • State Key Laboratory Fluid Power and Mechatronic Systems (CN)
  • Zhejiang University Medical College Affiliated Stomatological Hospital (CN)
  • Tongji University (CN)
  • University of Cambridge (GB)
Corresponding author
Ma, Liang
Venue
Regenerative Biomaterials
Published
2022-01-01
Volume
9
Pages
rbac079-rbac079
ISSN
  • 2056-3418 (ISSN-L)
  • 2056-3426
OpenAlex
W4304807955
Cited by
45
References
215
Citations by year
2026: 12 · 2025: 14 · 2024: 14 · 2023: 5
FWCI
0.73
Type
journal article
Language
en
Open access
Locations
  • Regenerative Biomaterials (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • National Natural Science Foundation of China (51875518, 52105310, 52275294, 2018YFA0703000)
  • National Key Research and Development Program of China (2018YFA0703000, 51875518)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
Keywords
liver tissue engineering, biomaterials, hepatocytes, stem cells, extracellular matrix, hydrogels, synthetic polymers, bioprinting, microfluidics, liver regeneration, liver transplantation, disease models, drug toxicity testing, vascularization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.